Curry International Tuberculosis Center
The Curry International Tuberculosis Center (CITC) creates, enhances and disseminates state-of-the-art resources and models of excellence and performs research to control and eliminate tuberculosis in the United States and internationally. Committed to the belief that everyone deserves the highest quality of care in a manner consistent with his or her culture, values and language, we develop and deliver highly versatile, culturally appropriate trainings and educational products, and provide technical assistance.
Philip Hopewell
Philip Hopewell, MD, is an internist in San Francisco, California, and is affiliated with multiple hospitals in the area, including UCSF Medical Center and the Zuckerberg San Francisco General Hospital and Trauma Center. A past president of the ATS, Dr. Hopewell has received major funding to study tuberculosis control internationally from the National Institute of Allergy and Infectious Diseases.
UN Special Envoy & Lancet Commission on TB
The Office of the UN Secretary-General’s Special Envoy on Tuberculosis works with the TB community to advance global efforts to end TB by 2030. The UN Special Envoy, Dr. Eric Goosby, MD, advocates for financial, political, scientific, and technical support necessary to achieve this ambitious goal.
